Autres langues Kamada Ltd.

Actions

KMDA

IL0010941198

Produits pharmaceutiques

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:28:56 22/07/2026			Varia. 5j.	Varia. 1 janv.
2 173,00 ^ILa	-1,27%		+1,02%	-3,85%

20/07	Kamada Ltd annonce un contrat de fourniture de plasma de 50 millions de dollars sur trois ans avec une société biopharmaceutique spécialisée	CI
20/07	Kamada signe un accord de fourniture de plasma de 50 millions de dollars avec une société biopharmaceutique	MT

Autres langues

20/07	Kamada Ltd Announces Three-Year USD 50 Million Supply Agreement To Supply Plasma To Biopharmaceutical Company Focused On Plasma-Derived Therapies
20/07	Kamada Signs $50 Million Plasma Supply Agreement With Biopharmaceutical Firm
20/07	Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
13/07	Kamada Ltd. Highlights CYTOGAM Study Results Presented at The 2026 ISHLT Annual Meeting
13/07	Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
01/06	Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
01/06	Kamada Announces FDA Approval of Its New In-House Rabies Virus Neutralization Testing Laboratory
13/05	Kamada: Q1 Earnings Snapshot
13/05	Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
13/05	Kamada Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
13/05	Kamada Ltd. Reiterates Earnings Guidance for the Fiscal Year 2026
06/05	Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
08/04	La historia de la semana: ¿Por qué el mercado bursátil israelí resiste tan bien?
31/03	Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
26/03	Kamada Says San Antonio Plasma Collection Center Received US FDA Approval
26/03	Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
26/03	Kamada Ltd Announces Fda Approval of Plasma Collection Center in San Antonio, Texas
26/03	Kamada Ltd. Announces FDA Approval Of Plasma Collection Center In San Antonio, Texas
11/03	Kamada Ltd. Reiterates Earnings Guidance for the Full Year of 2026
11/03	Kamada Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
11/03	Kamada Ltd. Declares Annual Cash Dividend, Payable on April 7, 2026
11/03	Kamada Sets Annual Cash Dividend of $0.25 per Share, Payable April 6 to Shareholders of Record as of March 23
11/03	Kamada : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)
11/03	Kamada: Q4 Earnings Snapshot
11/03	Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth